BioSpace News Archive

BioMidwest

Abeona Announces $13.85M Grant from Leading Sanfilippo Syndrome Foundations for Clinical Development of MPS III Gene Therapies

Nine global foundations collaborate to grant $13.85 million for the continued advancement of lead Sanfilippo gene therapy programs.

October 16, 2017

·

4 min read

Drug Development

Innate Pharma: IPH4102 - Final Results of the Dose-Escalation Part of the Phase I Study

Innate Pharma announces that final results of the dose-escalation part of the ongoing Phase I study investigating IPH4102 in patients with relapsed/refractory cutaneous T-cell lymphomas.

October 16, 2017

·

6 min read

Ablynx’s Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (The “Transparency Law”)

Ablynx received a notification of shareholdings from Consonance CapMan GP LLC on 11 October 2017.

October 16, 2017

·

4 min read

Drug Development

BioAegis Hires Dr. Mark J. DiNubile as Chief Medical Officer to Spearhead Forthcoming Phase II Clinical Trials in Community-Acquired Pneumonia

Dr. DiNubile brings to BioAegis the rare combination of clinical and research expertise along with broad pharmaceutical industry experience.

October 16, 2017

·

3 min read

Drug Development

Mithra Announces Completion Of Recruitment In Donesta Phase II Study

Mithra, a company specialized in Women’s Health, today announces the completion of recruitment in the E4 Relief Phase II study of Donesta.

October 16, 2017

·

5 min read

Business

Dentsply Sirona Announces Additions to Executive Leadership Team

Dentsply Sirona announced the appointment of two new Executive Leadership Team members, effective immediately.

October 16, 2017

·

5 min read

BGB324, BerGenBio’s Selective First-in-Class AXL Inhibitor, Featured in 3 Clinical Presentations At 18th World Conference On Lung Cancer In Yokohama

BerGenBio announces presentations on three ongoing Phase 2 clinical trials with BGB324 in lung cancer patients at the 18th World Conference on Lung Cancer in Yokohama, Japan.

October 16, 2017

·

6 min read

Biotech Beach

REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland

REVA Medical announced the commercial expansion of its bioresorbable scaffold (“BRS”), Fantom, with the first implant in Switzerland.

October 16, 2017

·

3 min read

Business

Batavia Biosciences Expands Its Viral Vector And GMP Facilities To Accommodate Increasing Market Demand

Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand.

October 16, 2017

·

1 min read

Almac Pod - Changing The Global Dynamics Of Temperature Controlled Shipping Solutions

Almac Group has recognized the need for a change in dynamics of temperature controlled shipping with the launch of its new Almac Pod service solution in the United States.

October 16, 2017

·

2 min read